- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-3170
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Glycaemic Effects of Non-statin Lipid-Lowering Therapies ; volume:18 ; number:12 ; day:19 ; month:11 ; year:2016 ; pages:1-5 ; date:12.2016
Current cardiology reports ; 18, Heft 12 (19.11.2016), 1-5, 12.2016
- Urheber
-
Collins, Patrick D.
- Beteiligte Personen und Organisationen
-
Sattar, Naveed
SpringerLink (Online service)
- DOI
-
10.1007/s11886-016-0795-9
- URN
-
urn:nbn:de:1111-201612227243
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Collins, Patrick D.
- Sattar, Naveed
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy
Lipid-lowering properties of protein-rich mucuna product
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Nicotinic acid: a lipid-lowering agent with unrealized potential
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy
Lipid-lowering properties of protein-rich mucuna product
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Nicotinic acid: a lipid-lowering agent with unrealized potential
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy
Lipid-lowering properties of protein-rich mucuna product
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Nicotinic acid: a lipid-lowering agent with unrealized potential
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C